AtriCure to Participate at Upcoming Investor Conferences
July 29 2020 - 8:00AM
Business Wire
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical
treatments for atrial fibrillation (Afib) and left atrial appendage
(LAA) management, today announced that the company will be
participating in several upcoming investor conferences.
AtriCure will be participating in the Guggenheim MedTech
Disruptors Summit, scheduled to be held virtually August 10-11,
2020. AtriCure’s management is scheduled to present on Monday,
August 10, 2020, at 10:00 a.m. Eastern Time.
AtriCure will be participating in the Canaccord Genuity 40th
Annual Growth Conference, scheduled to be held virtually August
11-13, 2020. AtriCure’s management is scheduled to present on
Thursday, August 13, 2020, at 9:00 a.m. Eastern Time. Interested
parties may access a live audio webcast of the presentation by
visiting the “Investors” section of the company’s website at
https://ir.atricure.com.
AtriCure management will be participating in 1x1 meetings at the
5th Annual Needham Med Tech Conference, scheduled to be held
virtually Monday, August 17, 2020.
About AtriCure
AtriCure, Inc. provides innovative technologies for the
treatment of Afib and related conditions. Afib affects more than 33
million people worldwide. Electrophysiologists and cardiothoracic
surgeons around the globe use AtriCure technologies for the
treatment of Afib and reduction of Afib related complications.
AtriCure’s Isolator® Synergy™ Ablation System is the first and only
medical device to receive FDA approval for the treatment of
persistent Afib. AtriCure’s AtriClip® Left Atrial Appendage
Exclusion System products are the most widely sold LAA management
devices worldwide. For more information, visit AtriCure.com or
follow us on Twitter @AtriCure.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200729005104/en/
Andy Wade AtriCure, Inc. Chief Financial Officer (513) 755-4564
awade@atricure.com
Lynn Pieper Lewis Gilmartin Group Investor Relations (415)
937-5402 lynn@gilmartinir.com
AtriCure (NASDAQ:ATRC)
Historical Stock Chart
From Mar 2024 to Apr 2024
AtriCure (NASDAQ:ATRC)
Historical Stock Chart
From Apr 2023 to Apr 2024